The structure of aggrecan and its turnover in cartilage
Affiliations
- PMID: 7752148
Item in Clipboard
The structure of aggrecan and its turnover in cartilage
J Rheumatol Suppl.
1995 Feb.
Abstract
Aggrecan is the major proteoglycan in cartilage. It has a multidomain structure with 3 globular and 2 extended segments. It forms large aggregates by binding to hyaluronan via the G1 domain, and link protein stabilizes the aggrecan-hyaluronan bond. The extended interglobular domain joining G1 and G2 domains is the main site of proteolytic attack in aggrecan turnover. One site of cleavage is reported to predominate, but the enzyme responsible for this cleavage has not been identified. A metalloproteinase, neutrophil collagenase, has been shown to cleave at this "aggrecanase" site in vitro; however, it has yet to be shown if metalloproteinases are responsible for this activity in cartilage.
Similar articles
-
The structure, function and turnover of aggrecan, the large aggregating proteoglycan from cartilage.Eur J Clin Chem Clin Biochem. 1994 Apr;32(4):249-57. Eur J Clin Chem Clin Biochem. 1994. PMID: 8038265 Review.
-
Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.J Clin Invest. 1997 Jul 1;100(1):93-106. doi: 10.1172/JCI119526. J Clin Invest. 1997. PMID: 9202061 Free PMC article.
-
Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro.Biochem J. 1999 Nov 15;344 Pt 1(Pt 1):61-8. Biochem J. 1999. PMID: 10548534 Free PMC article.
-
Structure and function of aggrecan.Cell Res. 2002 Mar;12(1):19-32. doi: 10.1038/sj.cr.7290106. Cell Res. 2002. PMID: 11942407 Review.
-
Catabolism of aggrecan by explant cultures of human articular cartilage in the presence of retinoic acid.Arch Biochem Biophys. 1995 Sep 10;322(1):22-30. doi: 10.1006/abbi.1995.1431. Arch Biochem Biophys. 1995. PMID: 7574678
Cited by
-
Computational insights into the substrate recognition mechanism of cartilage extracellular matrix degradation.Comput Struct Biotechnol J. 2021 Oct 6;19:5535-5545. doi: 10.1016/j.csbj.2021.10.002. eCollection 2021. Comput Struct Biotechnol J. 2021. PMID: 34712398 Free PMC article.
-
Chondrocytes and meniscal fibrochondrocytes differentially process aggrecan during de novo extracellular matrix assembly.Tissue Eng Part A. 2009 Jul;15(7):1513-22. doi: 10.1089/ten.tea.2008.0106. Tissue Eng Part A. 2009. PMID: 19260779 Free PMC article.
-
Articular cartilage destruction in experimental inflammatory arthritis: insulin-like growth factor-1 regulation of proteoglycan metabolism in chondrocytes.Histochem J. 1996 Dec;28(12):835-57. doi: 10.1007/BF02331388. Histochem J. 1996. PMID: 9015706 Review.
-
Patients with rheumatoid arthritis have an altered circulatory aggrecan profile.BMC Musculoskelet Disord. 2008 May 28;9:74. doi: 10.1186/1471-2474-9-74. BMC Musculoskelet Disord. 2008. PMID: 18507823 Free PMC article.
-
An aggrecan-degrading activity associated with chondrocyte membranes.Biochem J. 1998 Nov 15;336 ( Pt 1)(Pt 1):207-12. doi: 10.1042/bj3360207. Biochem J. 1998. PMID: 9806902 Free PMC article.